nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.172	0.266	CbGbCtD
Fomepizole—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.172	0.266	CbGbCtD
Fomepizole—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.13	0.201	CbGbCtD
Fomepizole—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0965	0.149	CbGbCtD
Fomepizole—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0764	0.118	CbGbCtD
Fomepizole—CAT—Detoxification of Reactive Oxygen Species—SOD3—chronic obstructive pulmonary disease	0.00781	0.0494	CbGpPWpGaD
Fomepizole—ADH1C—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00723	0.0457	CbGpPWpGaD
Fomepizole—ADH1B—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00723	0.0457	CbGpPWpGaD
Fomepizole—CAT—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.00718	0.0454	CbGpPWpGaD
Fomepizole—ADH1C—bronchus—chronic obstructive pulmonary disease	0.00675	0.0792	CbGeAlD
Fomepizole—CAT—respiratory system—chronic obstructive pulmonary disease	0.00644	0.0755	CbGeAlD
Fomepizole—ADH1A—trachea—chronic obstructive pulmonary disease	0.00618	0.0725	CbGeAlD
Fomepizole—ADH1C—trachea—chronic obstructive pulmonary disease	0.00607	0.0711	CbGeAlD
Fomepizole—ADH1A—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00599	0.0378	CbGpPWpGaD
Fomepizole—ADH1B—respiratory system—chronic obstructive pulmonary disease	0.0058	0.068	CbGeAlD
Fomepizole—CAT—connective tissue—chronic obstructive pulmonary disease	0.00567	0.0665	CbGeAlD
Fomepizole—CAT—bronchus—chronic obstructive pulmonary disease	0.0053	0.0621	CbGeAlD
Fomepizole—ADH1C—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00525	0.0332	CbGpPWpGaD
Fomepizole—ADH1B—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00525	0.0332	CbGpPWpGaD
Fomepizole—CAT—smooth muscle tissue—chronic obstructive pulmonary disease	0.00519	0.0608	CbGeAlD
Fomepizole—ADH1B—connective tissue—chronic obstructive pulmonary disease	0.00511	0.0599	CbGeAlD
Fomepizole—ADH1B—bronchus—chronic obstructive pulmonary disease	0.00477	0.056	CbGeAlD
Fomepizole—CAT—trachea—chronic obstructive pulmonary disease	0.00476	0.0558	CbGeAlD
Fomepizole—CAT—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.00468	0.0296	CbGpPWpGaD
Fomepizole—ADH1A—lung—chronic obstructive pulmonary disease	0.00444	0.0521	CbGeAlD
Fomepizole—ADH1C—lung—chronic obstructive pulmonary disease	0.00436	0.0511	CbGeAlD
Fomepizole—ADH1A—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00435	0.0275	CbGpPWpGaD
Fomepizole—ADH1B—trachea—chronic obstructive pulmonary disease	0.00429	0.0503	CbGeAlD
Fomepizole—CAT—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00382	0.0241	CbGpPWpGaD
Fomepizole—CAT—Detoxification of Reactive Oxygen Species—GSTP1—chronic obstructive pulmonary disease	0.00357	0.0226	CbGpPWpGaD
Fomepizole—Application site reaction—Salbutamol—chronic obstructive pulmonary disease	0.00343	0.0314	CcSEcCtD
Fomepizole—CAT—lung—chronic obstructive pulmonary disease	0.00342	0.0401	CbGeAlD
Fomepizole—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.00325	0.0297	CcSEcCtD
Fomepizole—CAT—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.00324	0.0205	CbGpPWpGaD
Fomepizole—ADH1B—lung—chronic obstructive pulmonary disease	0.00308	0.0361	CbGeAlD
Fomepizole—CAT—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00304	0.0192	CbGpPWpGaD
Fomepizole—CAT—Oxidative Stress—CYP1A1—chronic obstructive pulmonary disease	0.00286	0.0181	CbGpPWpGaD
Fomepizole—CAT—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0028	0.0177	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00257	0.0162	CbGpPWpGaD
Fomepizole—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.0214	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00204	0.0129	CbGpPWpGaD
Fomepizole—ADH1C—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00204	0.0129	CbGpPWpGaD
Fomepizole—ADH1B—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00204	0.0129	CbGpPWpGaD
Fomepizole—CAT—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00203	0.0128	CbGpPWpGaD
Fomepizole—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.002	0.0183	CcSEcCtD
Fomepizole—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.0172	CcSEcCtD
Fomepizole—ADH1A—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00169	0.0107	CbGpPWpGaD
Fomepizole—CYP2A6—lung—chronic obstructive pulmonary disease	0.00156	0.0182	CbGeAlD
Fomepizole—ADH1C—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00148	0.00934	CbGpPWpGaD
Fomepizole—ADH1B—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00148	0.00934	CbGpPWpGaD
Fomepizole—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.0132	CcSEcCtD
Fomepizole—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.0131	CcSEcCtD
Fomepizole—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.013	CcSEcCtD
Fomepizole—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.00138	0.0162	CbGeAlD
Fomepizole—CAT—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00135	0.00853	CbGpPWpGaD
Fomepizole—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.0121	CcSEcCtD
Fomepizole—ADH1C—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0013	0.00822	CbGpPWpGaD
Fomepizole—ADH1B—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0013	0.00822	CbGpPWpGaD
Fomepizole—ADH1B—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00129	0.00812	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00129	0.00812	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.00126	0.00797	CbGpPWpGaD
Fomepizole—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.0114	CcSEcCtD
Fomepizole—ADH1A—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00123	0.00774	CbGpPWpGaD
Fomepizole—CYP2A6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00116	0.00734	CbGpPWpGaD
Fomepizole—ADH1B—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00108	0.00683	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00108	0.00683	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00108	0.00681	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00107	0.00677	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00107	0.00673	CbGpPWpGaD
Fomepizole—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00964	CcSEcCtD
Fomepizole—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00962	CcSEcCtD
Fomepizole—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00954	CcSEcCtD
Fomepizole—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00952	CcSEcCtD
Fomepizole—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00948	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00104	0.00655	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.00103	0.00653	CbGpPWpGaD
Fomepizole—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00934	CcSEcCtD
Fomepizole—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00098	0.00895	CcSEcCtD
Fomepizole—CYP2A6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000972	0.00614	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TNF—chronic obstructive pulmonary disease	0.00095	0.006	CbGpPWpGaD
Fomepizole—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000947	0.00865	CcSEcCtD
Fomepizole—CYP2A6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000934	0.0059	CbGpPWpGaD
Fomepizole—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000934	0.00853	CcSEcCtD
Fomepizole—Hiccups—Prednisolone—chronic obstructive pulmonary disease	0.000923	0.00843	CcSEcCtD
Fomepizole—CYP2E1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000918	0.0058	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000902	0.0057	CbGpPWpGaD
Fomepizole—ADH1B—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000902	0.0057	CbGpPWpGaD
Fomepizole—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.0009	0.00823	CcSEcCtD
Fomepizole—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.0009	0.00822	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PLAU—chronic obstructive pulmonary disease	0.000897	0.00567	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000896	0.00566	CbGpPWpGaD
Fomepizole—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000893	0.00816	CcSEcCtD
Fomepizole—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00087	0.00795	CcSEcCtD
Fomepizole—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00085	0.00776	CcSEcCtD
Fomepizole—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00085	0.00776	CcSEcCtD
Fomepizole—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000848	0.00775	CcSEcCtD
Fomepizole—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000844	0.00533	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000842	0.00532	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TP53—chronic obstructive pulmonary disease	0.000838	0.00529	CbGpPWpGaD
Fomepizole—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000832	0.0076	CcSEcCtD
Fomepizole—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000831	0.00759	CcSEcCtD
Fomepizole—ADH1B—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000829	0.00523	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000829	0.00523	CbGpPWpGaD
Fomepizole—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000825	0.00754	CcSEcCtD
Fomepizole—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000825	0.00754	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000823	0.0052	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000822	0.00519	CbGpPWpGaD
Fomepizole—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00082	0.00749	CcSEcCtD
Fomepizole—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000802	0.00733	CcSEcCtD
Fomepizole—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000792	0.00724	CcSEcCtD
Fomepizole—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000786	0.00718	CcSEcCtD
Fomepizole—ADH1B—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000786	0.00496	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000786	0.00496	CbGpPWpGaD
Fomepizole—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00078	0.00712	CcSEcCtD
Fomepizole—CYP2E1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000768	0.00485	CbGpPWpGaD
Fomepizole—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000762	0.00696	CcSEcCtD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000757	0.00478	CbGpPWpGaD
Fomepizole—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000755	0.0069	CcSEcCtD
Fomepizole—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000755	0.0069	CcSEcCtD
Fomepizole—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000751	0.00686	CcSEcCtD
Fomepizole—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00075	0.00685	CcSEcCtD
Fomepizole—ADH1A—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000747	0.00472	CbGpPWpGaD
Fomepizole—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000747	0.00682	CcSEcCtD
Fomepizole—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000741	0.00677	CcSEcCtD
Fomepizole—CYP2E1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000738	0.00466	CbGpPWpGaD
Fomepizole—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000735	0.00672	CcSEcCtD
Fomepizole—CYP2E1—lung—chronic obstructive pulmonary disease	0.000735	0.00862	CbGeAlD
Fomepizole—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00073	0.00667	CcSEcCtD
Fomepizole—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00073	0.00667	CcSEcCtD
Fomepizole—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000721	0.00659	CcSEcCtD
Fomepizole—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000721	0.00659	CcSEcCtD
Fomepizole—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000712	0.0065	CcSEcCtD
Fomepizole—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000707	0.00646	CcSEcCtD
Fomepizole—CYP2A6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000706	0.00446	CbGpPWpGaD
Fomepizole—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000703	0.00643	CcSEcCtD
Fomepizole—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000695	0.00635	CcSEcCtD
Fomepizole—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000689	0.00629	CcSEcCtD
Fomepizole—ADH1A—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000687	0.00434	CbGpPWpGaD
Fomepizole—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000685	0.00626	CcSEcCtD
Fomepizole—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.00626	CcSEcCtD
Fomepizole—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00622	CcSEcCtD
Fomepizole—CYP2A6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000679	0.00429	CbGpPWpGaD
Fomepizole—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000671	0.00613	CcSEcCtD
Fomepizole—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000671	0.00613	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000669	0.00423	CbGpPWpGaD
Fomepizole—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000667	0.00421	CbGpPWpGaD
Fomepizole—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000663	0.00606	CcSEcCtD
Fomepizole—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000653	0.00597	CcSEcCtD
Fomepizole—ADH1A—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000651	0.00411	CbGpPWpGaD
Fomepizole—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000647	0.00591	CcSEcCtD
Fomepizole—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000632	0.00578	CcSEcCtD
Fomepizole—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00578	CcSEcCtD
Fomepizole—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00578	CcSEcCtD
Fomepizole—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00578	CcSEcCtD
Fomepizole—ADH1B—Metabolism—APIP—chronic obstructive pulmonary disease	0.000632	0.00399	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—APIP—chronic obstructive pulmonary disease	0.000632	0.00399	CbGpPWpGaD
Fomepizole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000632	0.00577	CcSEcCtD
Fomepizole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000632	0.00577	CcSEcCtD
Fomepizole—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000619	0.00566	CcSEcCtD
Fomepizole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000616	0.00563	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000611	0.00386	CbGpPWpGaD
Fomepizole—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00545	CcSEcCtD
Fomepizole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000596	0.00544	CcSEcCtD
Fomepizole—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000594	0.00542	CcSEcCtD
Fomepizole—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000594	0.00542	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.000576	0.00364	CbGpPWpGaD
Fomepizole—CAT—Metabolism—APIP—chronic obstructive pulmonary disease	0.000569	0.00359	CbGpPWpGaD
Fomepizole—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00519	CcSEcCtD
Fomepizole—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00519	CcSEcCtD
Fomepizole—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.00516	CcSEcCtD
Fomepizole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00056	0.00512	CcSEcCtD
Fomepizole—CYP2E1—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000558	0.00352	CbGpPWpGaD
Fomepizole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000547	0.00499	CcSEcCtD
Fomepizole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000541	0.00494	CcSEcCtD
Fomepizole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000541	0.00494	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000539	0.0034	CbGpPWpGaD
Fomepizole—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.0049	CcSEcCtD
Fomepizole—CYP2E1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000537	0.00339	CbGpPWpGaD
Fomepizole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00489	CcSEcCtD
Fomepizole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00489	CcSEcCtD
Fomepizole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00053	0.00484	CcSEcCtD
Fomepizole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000528	0.00483	CcSEcCtD
Fomepizole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00479	CcSEcCtD
Fomepizole—ADH1A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000524	0.00331	CbGpPWpGaD
Fomepizole—Pain—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00475	CcSEcCtD
Fomepizole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00475	CcSEcCtD
Fomepizole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00051	0.00466	CcSEcCtD
Fomepizole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000509	0.00465	CcSEcCtD
Fomepizole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000508	0.00464	CcSEcCtD
Fomepizole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.00462	CcSEcCtD
Fomepizole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.0046	CcSEcCtD
Fomepizole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.0046	CcSEcCtD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000502	0.00317	CbGpPWpGaD
Fomepizole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000501	0.00457	CcSEcCtD
Fomepizole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000499	0.00456	CcSEcCtD
Fomepizole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.00455	CcSEcCtD
Fomepizole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000497	0.00454	CcSEcCtD
Fomepizole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000497	0.00454	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000493	0.00311	CbGpPWpGaD
Fomepizole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00449	CcSEcCtD
Fomepizole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000487	0.00445	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000485	0.00307	CbGpPWpGaD
Fomepizole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000481	0.00439	CcSEcCtD
Fomepizole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000481	0.00439	CcSEcCtD
Fomepizole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000481	0.00439	CcSEcCtD
Fomepizole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000481	0.00439	CcSEcCtD
Fomepizole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000479	0.00438	CcSEcCtD
Fomepizole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00434	CcSEcCtD
Fomepizole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00434	CcSEcCtD
Fomepizole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000475	0.00434	CcSEcCtD
Fomepizole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000472	0.00431	CcSEcCtD
Fomepizole—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000472	0.00431	CcSEcCtD
Fomepizole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000471	0.0043	CcSEcCtD
Fomepizole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000471	0.0043	CcSEcCtD
Fomepizole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00047	0.00429	CcSEcCtD
Fomepizole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.00415	CcSEcCtD
Fomepizole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.00415	CcSEcCtD
Fomepizole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000448	0.00409	CcSEcCtD
Fomepizole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000447	0.00408	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TGFB1—chronic obstructive pulmonary disease	0.000438	0.00277	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000419	0.00264	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000419	0.00264	CbGpPWpGaD
Fomepizole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.0038	CcSEcCtD
Fomepizole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000416	0.0038	CcSEcCtD
Fomepizole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00372	CcSEcCtD
Fomepizole—ADH1C—Metabolism—GC—chronic obstructive pulmonary disease	0.000407	0.00257	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GC—chronic obstructive pulmonary disease	0.000407	0.00257	CbGpPWpGaD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.00255	CbGpPWpGaD
Fomepizole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00367	CcSEcCtD
Fomepizole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00367	CcSEcCtD
Fomepizole—CYP2A6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000398	0.00252	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000395	0.0025	CbGpPWpGaD
Fomepizole—CYP2E1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000394	0.00249	CbGpPWpGaD
Fomepizole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000394	0.0036	CcSEcCtD
Fomepizole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00359	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000392	0.00247	CbGpPWpGaD
Fomepizole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00353	CcSEcCtD
Fomepizole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00353	CcSEcCtD
Fomepizole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.0035	CcSEcCtD
Fomepizole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000383	0.0035	CcSEcCtD
Fomepizole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000383	0.0035	CcSEcCtD
Fomepizole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.0035	CcSEcCtD
Fomepizole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00348	CcSEcCtD
Fomepizole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00348	CcSEcCtD
Fomepizole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00038	0.00347	CcSEcCtD
Fomepizole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00347	CcSEcCtD
Fomepizole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00346	CcSEcCtD
Fomepizole—ADH1C—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000379	0.00239	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000379	0.00239	CbGpPWpGaD
Fomepizole—CAT—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000377	0.00238	CbGpPWpGaD
Fomepizole—Rash—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00343	CcSEcCtD
Fomepizole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00343	CcSEcCtD
Fomepizole—Headache—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00341	CcSEcCtD
Fomepizole—CAT—Metabolism—GC—chronic obstructive pulmonary disease	0.000367	0.00232	CbGpPWpGaD
Fomepizole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00334	CcSEcCtD
Fomepizole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.00331	CcSEcCtD
Fomepizole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00331	CcSEcCtD
Fomepizole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.0033	CcSEcCtD
Fomepizole—CYP2A6—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000361	0.00228	CbGpPWpGaD
Fomepizole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.0033	CcSEcCtD
Fomepizole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000361	0.0033	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TP53—chronic obstructive pulmonary disease	0.000361	0.00228	CbGpPWpGaD
Fomepizole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00329	CcSEcCtD
Fomepizole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000354	0.00323	CcSEcCtD
Fomepizole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.00319	CcSEcCtD
Fomepizole—ADH1A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000347	0.00219	CbGpPWpGaD
Fomepizole—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000343	0.00313	CcSEcCtD
Fomepizole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00312	CcSEcCtD
Fomepizole—CAT—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000341	0.00215	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GC—chronic obstructive pulmonary disease	0.000337	0.00213	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000327	0.00207	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000326	0.00206	CbGpPWpGaD
Fomepizole—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000324	0.00296	CcSEcCtD
Fomepizole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.00294	CcSEcCtD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000319	0.00201	CbGpPWpGaD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000315	0.00199	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000314	0.00198	CbGpPWpGaD
Fomepizole—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000313	0.00286	CcSEcCtD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000293	0.00185	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.00029	0.00183	CbGpPWpGaD
Fomepizole—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000289	0.00183	CbGpPWpGaD
Fomepizole—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000287	0.00181	CbGpPWpGaD
Fomepizole—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.00257	CcSEcCtD
Fomepizole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000276	0.00252	CcSEcCtD
Fomepizole—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00248	CcSEcCtD
Fomepizole—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00246	CcSEcCtD
Fomepizole—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00241	CcSEcCtD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00163	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000258	0.00163	CbGpPWpGaD
Fomepizole—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00232	CcSEcCtD
Fomepizole—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00227	CcSEcCtD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000238	0.0015	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000236	0.00149	CbGpPWpGaD
Fomepizole—Shock—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00215	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	0.000235	0.00149	CbGpPWpGaD
Fomepizole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00213	CcSEcCtD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000232	0.00146	CbGpPWpGaD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.00144	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000223	0.00141	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000222	0.00141	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000222	0.00141	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00022	0.00139	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00022	0.00139	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000219	0.00138	CbGpPWpGaD
Fomepizole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00199	CcSEcCtD
Fomepizole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00192	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000209	0.00132	CbGpPWpGaD
Fomepizole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000208	0.0019	CcSEcCtD
Fomepizole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.0019	CcSEcCtD
Fomepizole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.0019	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000207	0.00131	CbGpPWpGaD
Fomepizole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00189	CcSEcCtD
Fomepizole—ADH1B—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000201	0.00127	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000201	0.00127	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.0002	0.00127	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000198	0.00125	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00179	CcSEcCtD
Fomepizole—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00179	CcSEcCtD
Fomepizole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00173	CcSEcCtD
Fomepizole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00173	CcSEcCtD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00119	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000185	0.00117	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000185	0.00117	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000184	0.00116	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000182	0.00115	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000181	0.00114	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	0.000178	0.00112	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000174	0.0011	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000167	0.00106	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.00105	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000166	0.00105	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000165	0.00104	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000165	0.00104	CbGpPWpGaD
Fomepizole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000164	0.0015	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000163	0.00103	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000163	0.00103	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	0.000163	0.00103	CbGpPWpGaD
Fomepizole—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00145	CcSEcCtD
Fomepizole—ADH1B—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000154	0.000974	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000154	0.000974	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.000968	CbGpPWpGaD
Fomepizole—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00139	CcSEcCtD
Fomepizole—ADH1C—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000152	0.000961	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000152	0.000961	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000152	0.000959	CbGpPWpGaD
Fomepizole—Rash—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00138	CcSEcCtD
Fomepizole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00138	CcSEcCtD
Fomepizole—Headache—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00137	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000145	0.000915	CbGpPWpGaD
Fomepizole—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000142	0.0013	CcSEcCtD
Fomepizole—ADH1C—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000142	0.000895	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000142	0.000895	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000139	0.000877	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.000867	CbGpPWpGaD
Fomepizole—CAT—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000137	0.000865	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.000855	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.000849	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.000849	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000133	0.000841	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000128	0.000807	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000128	0.000806	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.000797	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000126	0.000796	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.000764	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000117	0.000742	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000115	0.000723	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000113	0.000713	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.000703	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000105	0.000665	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000104	0.000656	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000102	0.000642	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.98e-05	0.00063	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.84e-05	0.000622	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ALB—chronic obstructive pulmonary disease	9.13e-05	0.000577	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ALB—chronic obstructive pulmonary disease	9.13e-05	0.000577	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—NOS3—chronic obstructive pulmonary disease	8.73e-05	0.000552	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—NOS3—chronic obstructive pulmonary disease	8.73e-05	0.000552	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ALB—chronic obstructive pulmonary disease	8.22e-05	0.000519	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	8.03e-05	0.000507	CbGpPWpGaD
Fomepizole—CAT—Metabolism—NOS3—chronic obstructive pulmonary disease	7.86e-05	0.000497	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ALB—chronic obstructive pulmonary disease	7.57e-05	0.000478	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—NOS3—chronic obstructive pulmonary disease	7.24e-05	0.000457	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.73e-05	0.000425	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	6.54e-05	0.000413	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	6.19e-05	0.000391	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.08e-05	0.000384	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.32e-05	0.000336	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	5.17e-05	0.000327	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.81e-05	0.000304	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.58e-05	0.000226	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.53e-05	0.000223	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.22e-05	0.000204	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.97e-05	0.000188	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.83e-05	0.000178	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.79e-05	0.000176	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.55e-05	0.000161	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.48e-05	0.000157	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.44e-05	0.000154	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.35e-05	0.000148	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.28e-05	0.000144	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.16e-05	0.000136	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.96e-05	0.000124	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.93e-05	0.000122	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.8e-05	0.000114	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.71e-05	0.000108	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.47e-05	9.27e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.4e-05	8.87e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-05	7.33e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-05	7.01e-05	CbGpPWpGaD
